HAL (France)open access
Sustained Therapeutic Efficacy of siPMP22-Squalene Nanoparticles in the C61 Mouse Model of CMT1A: A Preclinical Case Study for Clinical Translation
C61 CMT1A mouse model, Long-lasting therapeutic effect, 0, Gene silencing, SiRNA PMP22-squalene nanoparticles, 2, Safety profile, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 395467
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.